Table 3.
Sequence variation |
14408C>T (RdRp: p.Pro312Leu) |
22189_22191delTAT (S: p.Ile210del) |
22992G>A (S: p.Ser477Asn) |
23403A>G (S: p.Asp614Gly) |
25563G>T (ORF3a: p.Gln57His) |
28688T>C (N: p.Leu139Phe) |
28835T>C (N: p.Ser188Pro) |
28854C>T (N: p.Ser194Leu) |
28881G>A (N: p.Arg203Lys) |
28882G>A (N: p.Arg203Arg) |
28883G>C (N: p.Gly204Arg) |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
Associated haplotype*/Virus strain** |
H1/G |
H1/G |
H1b/GH |
H5 |
H5 linked |
H1b linked |
H1a/GR |
H1a/GR |
H1a/GR |
|||
Variation ID | V1 | V2 | V3 | V4 | V5 | V6 | V7 | V8 | V9 | V10 | V11 | |
Genome type# | No. Samples in Tehran (Total: 14) | |||||||||||
D | 4 | + | . | . | + | . | + | + | . | . | . | . |
L | 3 | + | + | . | + | + | + | + | . | . | . | . |
M | 2 | + | + | . | + | . | + | + | . | . | . | . |
Tehran samples proposed to be infected with two viruses | ||||||||||||
No. Samples (ID) | ||||||||||||
D and H1 | 1 (T-30) | + | . | . | + | . | T/C | T/C | . | . | . | . |
A and D | 1 (T-20) | + | . | . | + | . | T/C | T/C | . | G/A | G/A | G/C |
C and L | 1 (T-13) | + | + | . | + | + | T/C | T/C | C/T | . | . | . |
M and L | 1 (T-18) | + | + | . | + | G/T | + | + | . | . | . | . |
M and N | 1 (T-26) | + | + | . | + | . | T/C | T/C | . | . | . | . |
Samples from provinces outside of Tehran | ||||||||||||
Mashhad | 4 samples | + | + | . | + | |||||||
Mashhad | 1 samples | + | . | . | + | |||||||
Ahvaz | 5 samples | + | + | . | + | |||||||
Shiraz | 5 samples | + | . | . | + |
X, Summary of data presented in Table S2; *, Haplotypes described in Safari et al, (2021a); **, virus strains described in GISAID; #, each type refers to a genome with a unique combination of sequence variations. +: variant sequence:., reference sequence, empty cell: not sequenced.